HOUSE_OVERSIGHT_024797.jpg

1.02 MB

Extraction Summary

0
People
8
Organizations
4
Locations
0
Events
0
Relationships
0
Quotes

Document Information

Type: Investment report / industry analysis
File Size: 1.02 MB
Summary

This document is page 161 of a 2018 report by Ackrell Capital titled 'Top 100 Private Cannabis Companies.' It profiles four specific companies: Trellis, Trulieve, Utopia Farms, and VapeWorld, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024797, indicating it was part of a document production to the House Oversight Committee.

Full Extracted Text

Complete text extracted from the document (1,331 characters)

ACKRELL
CAPITAL
CHAPTER VIII Top 100 Private Cannabis Companies 2018
Trellis
trellis
Oakland, California
www.trellisgrows.com
Trellis provides inventory-management software for the cannabis industry. The company provides software to aid cultivators, producers and dispensary operators in tracking their business from seed to sale. The software is designed to aid customers in compliance.
Trulieve
Trulieve
Quincy, Florida
www.trulieve.com
Trulieve is an operator of medical cannabis dispensaries in Florida, offering a selection of concentrates in the form of capsules, syringes, tinctures and vaporizers. The company also maintains its own cannabis cultivation facility.
Utopia Farms
UTOPIA FARMS
Santa Cruz, California
www.utopiafarms.org
Utopia Farms is a producer of branded cannabis products. The company produces cannabis flower, concentrates and cannabis-infused macaroons that are available in dispensaries throughout California.
VapeWorld
VapeWorld
Boca Raton, Florida
www.vapeworld.com
VapeWorld operates an online e-commerce website dedicated to cannabis accessories. Vaporizers from leading manufacturers, as well as parts and accessories, are available on its website. The company also provides consumers with online content about vaping.
© 2017 Ackrell Capital, LLC | Member FINRA/SIPC
161
HOUSE_OVERSIGHT_024797

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document